Announced Fri, 4 Sept, 2026 · 10:08 IST
Annual Report FY26: Loss narrows to Rs 3.13L on Rs 563.16L sales
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Annual report for FY26 shows net loss narrowed sharply to Rs 3.13L from Rs 74.83L last year. Gross sales slipped 4.8% to Rs 563.16L from Rs 591.60L. Company markets dental and skin care brands Cavisan, Cavidine and Nixoderm. No dividend due to carried forward losses of Rs 495.09L. Both auditor and secretarial audit reports are clean. AGM scheduled Sept 28, 2026.
Likely market impact
Loss narrowing is positive but accumulated losses persist at Rs 495L and no dividend. Watch for sales recovery and sustained turnaround.